Product Information
TERBUTALINE SULFATE 2.5 MG TAB is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.9467 per EA under NDC 24979013201. Its NADAC has been published 211 times since Sep 21, 2022.
FDA first approved this application on Jun 19, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
24979013201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TERBUTALINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA211832FDA Approved
6/19/2020
TE Code
AB
On Market Since
7/13/2020
Price Statistics
The NADAC for TERBUTALINE SULFATE 2.5 MG TAB has been published 211 times since Sep 21, 2022, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9467 per EA |
|---|---|
| All-time high | $1.7835 (Mar 15, 2023) |
| All-time low | $0.8532 (Oct 23, 2024) |
| 52-week high | $1.1002 |
| 52-week low | $0.8931 |
| Median price | $1.0978 |
| Average price | $1.2584 |
| Largest weekly change | -38.5% (Apr 17, 2024) |
| Weeks tracked | 211 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Terbutaline Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TERBUTALINE SULFATE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TERBUTALINE SULFATE 2.5 MG TAB, manufactured by Upsher-Smith Laboratories LLC, is $0.9467 per EA (NDC 24979013201), effective Sep 30, 2026.
How has the price of TERBUTALINE SULFATE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for TERBUTALINE SULFATE 2.5 MG TAB has declined 46.9%. It has been tracked across 211 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for TERBUTALINE SULFATE 2.5 MG TAB?
Since Sep 21, 2022, the NADAC for TERBUTALINE SULFATE 2.5 MG TAB has ranged from a low of $0.8532 (Oct 23, 2024) to a high of $1.7835 (Mar 15, 2023), with a median of $1.0978 per EA.
Are there cheaper alternatives to TERBUTALINE SULFATE 2.5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERBUTALINE SULFATE 2.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TERBUTALINE SULFATE 2.5 MG TAB?
TERBUTALINE SULFATE 2.5 MG TAB (NDC 24979013201) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.